Congress Trading GSK
23 members of Congress have disclosed 87 trades in GSK under the STOCK Act. Amounts are official disclosure ranges; volume estimates use band midpoints.
GSK
Net: mixed
Updated Sep 27, 2026
See politician-tracking strategies
Preview only · Never custodial
Official STOCK Act filingsMember-level trade countsDisclosure lag visible
Members trading
23
Disclosed trades
87
Purchases
55
Sales
32
Est. buy volume
$679K
Est. sell volume
$796K
Members trading GSK
Ranked by disclosed GSK trade count. Net volume uses band midpoints from the filing ranges.
| Member | Trades | Buys / Sells | Net direction | Est. net | Last trade |
|---|---|---|---|---|---|
| Virginia Foxx Republican · House | 29 | 27B / 2S | mixed | $113K | Mar 1, 2023 |
| Katherine M. Clark Democrat · House | 12 | 6B / 6S | mixed | $0 | Jun 4, 2021 |
| Lisa Mcclain Republican · House | 6 | 3B / 3S | mixed | $0 | Oct 31, 2025 |
| Bob Corker Republican · Senate | 5 | 4B / 1S | mixed | -$499 | May 20, 2014 |
| Greg Gianforte Republican · Senate | 4 | 2B / 2S | mixed | -$25K | Mar 18, 2020 |
| Michael T. McCaul Republican · House | 4 | 2B / 2S | selling | -$49K | Feb 24, 2016 |
| Pete Sessions Republican · House | 3 | 2B / 1S | mixed | $8K | Oct 25, 2017 |
| Valerie Hoyle Democrat · House | 2 | 1B / 1S | mixed | $0 | Sep 23, 2025 |
| Bruce Westerman Republican · House | 2 | 1B / 1S | mixed | $0 | Apr 21, 2025 |
| Tommy Tuberville Republican · Senate | 2 | 1B / 1S | mixed | $0 | Oct 16, 2023 |
| John Rutherford Republican · House | 2 | 1B / 1S | mixed | $0 | Feb 17, 2022 |
| Zoe Lofgren Democrat · House | 2 | 1B / 1S | mixed | $0 | Aug 30, 2018 |
| Kenneth R. Buck Republican · House | 2 | 1B / 1S | mixed | $0 | Nov 7, 2017 |
| Patty Murray Democrat · Senate | 2 | 1B / 1S | mixed | $0 | Jun 15, 2017 |
| Nicholas Van Taylor Republican · House | 2 | 0B / 2S | selling | -$65K | Mar 25, 2019 |
| E. Scott Rigell Republican · House | 1 | 1B / 0S | buying | $33K | Mar 8, 2016 |
| Marjorie Taylor Greene Republican · House | 1 | 1B / 0S | buying | $8K | Nov 25, 2024 |
| Robert B. Aderholt Republican · House | 1 | 0B / 1S | selling | -$8K | Jul 28, 2025 |
| Daniel Goldman Democrat · House | 1 | 0B / 1S | selling | -$33K | Jul 10, 2023 |
| Charlie Joseph Crist Democrat · House | 1 | 0B / 1S | selling | -$75K | Feb 22, 2017 |
| Thomas Macarthur Republican · House | 1 | 0B / 1S | selling | -$8K | May 27, 2015 |
| K. Michael Conaway Republican · House | 1 | 0B / 1S | selling | -$8K | Apr 27, 2015 |
| Thomas J. Rooney Republican · House | 1 | 0B / 1S | selling | -$8K | Jul 29, 2014 |
Recent GSK disclosures
Latest STOCK Act filings mentioning GSK.
| Trade date | Member | Type | Amount | Excess return | Filed |
|---|---|---|---|---|---|
| Oct 31, 2025 | Lisa Mcclain | Sale | $50M+ | -8.3% | Nov 21, 2025 |
| Oct 30, 2025 | Lisa Mcclain | Sale | $50M+ | -8.8% | Nov 21, 2025 |
| Oct 30, 2025 | Lisa Mcclain | Purchase | $50M+ | -8.8% | Nov 21, 2025 |
| Sep 23, 2025 | Valerie Hoyle | Sale | $50M+ | +5.3% | Oct 10, 2025 |
| Aug 4, 2025 | Lisa Mcclain | Purchase | $50M+ | +8.2% | Sep 12, 2025 |
| Jul 28, 2025 | Robert B. Aderholt | Sale | $50M+ | +10.1% | Sep 10, 2025 |
| Jun 24, 2025 | Lisa Mcclain | Sale | $50M+ | +0.3% | Aug 13, 2025 |
| Jun 17, 2025 | Lisa Mcclain | Purchase | $50M+ | -5.4% | Aug 13, 2025 |
| Apr 21, 2025 | Bruce Westerman | Sale | $50M+ | -15.4% | May 12, 2025 |
| Mar 3, 2025 | Bruce Westerman | Purchase | $50M+ | -2.6% | Apr 16, 2025 |
| Nov 25, 2024 | Marjorie Taylor Greene | Purchase | $50M+ | +14.8% | Nov 27, 2024 |
| Nov 18, 2024 | Valerie Hoyle | Purchase | $50M+ | +14.7% | Sep 12, 2025 |
| Oct 16, 2023 | Tommy Tuberville | Sale (Full) | $50M+ | -42.8% | Nov 16, 2023 |
| Jul 10, 2023 | Daniel Goldman | Sale | $50M+ | -30.5% | Aug 13, 2023 |
| Apr 3, 2023 | Tommy Tuberville | Purchase | $50M+ | -51.3% | May 11, 2023 |
| Mar 1, 2023 | Virginia Foxx | Sale | $50M+ | -52.2% | Apr 4, 2023 |
| Aug 16, 2022 | Virginia Foxx | Purchase | $50M+ | -40.3% | Sep 8, 2022 |
| Aug 10, 2022 | Virginia Foxx | Purchase | $50M+ | -55.5% | Sep 8, 2022 |
| Aug 9, 2022 | Virginia Foxx | Purchase | $50M+ | -65.0% | Sep 8, 2022 |
| Aug 5, 2022 | Virginia Foxx | Purchase | $50M+ | -65.7% | Sep 8, 2022 |
| Jul 12, 2022 | Virginia Foxx | Sale | $50M+ | -108.0% | Aug 5, 2022 |
| Jul 6, 2022 | Virginia Foxx | Purchase | $50M+ | -110.4% | Aug 5, 2022 |
| Apr 8, 2022 | Virginia Foxx | Purchase | $50M+ | -88.3% | May 4, 2022 |
| Feb 22, 2022 | Virginia Foxx | Purchase | $50M+ | -87.7% | Mar 7, 2022 |
| Feb 17, 2022 | John Rutherford | Sale | $50M+ | -85.9% | Mar 16, 2022 |
| Jan 14, 2022 | Virginia Foxx | Purchase | $50M+ | -79.7% | Feb 4, 2022 |
| Oct 8, 2021 | Virginia Foxx | Purchase | $50M+ | -74.8% | Nov 2, 2021 |
| Jul 9, 2021 | Virginia Foxx | Purchase | $50M+ | -79.5% | Aug 2, 2021 |
| Jun 4, 2021 | Katherine M. Clark | Sale | $50M+ | -81.7% | Aug 15, 2021 |
| Jun 4, 2021 | Katherine M. Clark | Sale | $50M+ | -81.7% | Aug 15, 2021 |
| Apr 9, 2021 | Virginia Foxx | Purchase | $50M+ | -80.4% | May 5, 2021 |
| Jan 15, 2021 | Virginia Foxx | Purchase | $50M+ | -103.4% | Feb 1, 2021 |
| Nov 5, 2020 | Katherine M. Clark | Purchase | $50M+ | -113.8% | Dec 28, 2020 |
| Nov 5, 2020 | Katherine M. Clark | Purchase | $50M+ | -113.8% | Dec 28, 2020 |
| Oct 22, 2020 | Katherine M. Clark | Sale | $50M+ | -112.3% | Dec 3, 2020 |
| Oct 22, 2020 | Katherine M. Clark | Sale | $50M+ | -112.3% | Dec 3, 2020 |
| Oct 9, 2020 | Virginia Foxx | Purchase | $50M+ | -118.3% | Nov 6, 2020 |
| Jul 10, 2020 | Virginia Foxx | Purchase | $50M+ | -144.9% | Aug 10, 2020 |
| Apr 13, 2020 | Virginia Foxx | Purchase | $50M+ | -179.6% | May 4, 2020 |
| Mar 18, 2020 | Greg Gianforte | Purchase | $50M+ | -207.9% | Apr 7, 2020 |
Frequently asked questions
Which members of Congress trade GSK?
23 tracked members have disclosed GSK trades. The most active include Virginia Foxx, Katherine M. Clark, Lisa Mcclain, Bob Corker, Greg Gianforte. Each row shows buy/sell counts and estimated band-midpoint volume from official STOCK Act filings.
Is Congress buying or selling GSK?
Across disclosed share trades, the net direction estimate is "mixed" (band midpoints: purchases $679K, sales $796K). Ranges can overlap, so direction is only reported when the bands prove it.
How fresh is the GSK Congress trading data?
Filings can lag the trade date by up to 45 days. This page refreshes from official House and Senate disclosure records; the snapshot timestamp is Sep 27, 2026.
Can Tengu research Congress trades in GSK?
Yes. Tengu can research disclosed GSK trades against your own holdings and draft an order that routes to your broker only after you approve it. Your money stays at your broker.